Get started
Author

Giuseppe Licci

Observed name: G. Licci
ORCID: 0000-0002-8124-3607
Observed ORCID: 0000-0002-8124-3607
OpenAlex ID: A5034290137
Non-Surgical Strategies for Assisting Closure of Pharyngocutaneous Fistula after Total Laryngectomy: A Systematic Review of the Literature
2021 · Luca Giovanni Locatello, Giuseppe Licci, et al. · Journal of Clinical Medicine · 32
PDF
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report
2023 · Pietro Orlando, Giuseppe Licci, et al. · European Archives of Oto-Rhino-Laryngology · 25
Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature
2024 · Marella Reale, Giuseppe Licci, et al. · European Archives of Oto-Rhino-Laryngology · 24
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study
2024 · Pietro Orlando, Emanuele Vivarelli, et al. · European Archives of Oto-Rhino-Laryngology · 17
PDF
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type‐2 CRSwNP Over 48 Months
2025 · Pietro Orlando, Giuseppe Licci, et al. · The Laryngoscope · 11
Mepolizumab Reduces Inflammatory Eosinophils in Nasal Polyp Tissue and Restores Histological Alterations
2025 · Andrea Matucci, Mato Accinno, et al. · Journal of Investigational Allergology and Clinical Immunology · 9
PDF
Cystic fibrosis-related chronic rhinosinusitis: the key role of a comprehensive evaluation in the era of highly effective modulator therapy
2024 · Alberto Minzoni, Luca Mazzetti, et al. · European Archives of Oto-Rhino-Laryngology · 9
Treating benign paroxysmal positional vertigo of the lateral semicircular canal with a shortened forced position
2023 · Beatrice Giannoni, Rudi Pecci, et al. · Frontiers in Neurology · 6
PDF
Low levels of miR-34c in nasal washings as a candidate marker of aggressive disease in wood and leather exposed workers with sinonasal intestinal-type adenocarcinomas (ITACs)
2022 · Elisabetta Bigagli, Giandomenico Maggiore, et al. · Translational Oncology · 6
PDF
Asthma Phenotype Can Be Influenced by Recurrent Respiratory Infections in Patients with Primary Antibody Deficiency: The Impact of Ig Therapy
2025 · Emanuele Vivarelli, Margherita Perlato, et al. · Respiration · 2
The Same–Up–Down Staging System for Recurrent Early Glottic Cancer
2023 · Giuseppe Licci, Luca Giovanni Locatello, et al. · Cancers · 2
PDF
The Utility of Intranasal Corticosteroids in Association With Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis: A Real‐Life Multicenter Study by a Tuscany Group
2025 · Pietro Orlando, Giuseppe Licci, et al. · World Journal of Otorhinolaryngology - Head and Neck Surgery · 1
PDF
Outcomes and Prognostic Factors of Salvage Surgery for Recurrent Oral Squamous Cell Carcinoma
2026 · Pietro Orlando, Letizia Flammia, et al. · Cancers
All or Nothing in Surgical Treatment of Precancerous Oral Cavity Lesions
2024 · Giuseppe Licci, Oreste Gallo · JAMA Otolaryngology–Head & Neck Surgery
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?
2024 · Giuseppe Fancello, Serena Jiang, et al. · Oral Oncology
Republication de : Letter in reply to “The first wave of COVID-19 did not cause longer wait times in head and neck cancer. Experience of a French expert center” by Vanderhaegen et al. Ann Otorhinolaryngol Head Neck Dis 2022;139:261–267
2023 · P. Orlando, G. Licci, et al. · Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale
Letter in reply to “the first wave of COVID-19 did not cause longer wait times in head and neck cancer. Experience of a French expert center” by Vanderhaegen et al. Ann Otorhinolaryngol Head Neck Dis 2022; 139:261-267
2023 · P. Orlando, G. Licci, et al. · European Annals of Otorhinolaryngology Head and Neck Diseases
Works count: 17
Citation count: 144
H-index: 7
I10-index: 5
Year
Topic
Type